Sep 26 |
Anebulo Pharmaceuticals GAAP EPS of -$0.05
|
Sep 25 |
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates
|
Sep 22 |
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation
|
Jul 22 |
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects
|
Jul 1 |
Lifecore Biomedical Announces Cooperation Agreement with 22NW
|
May 16 |
Anebulo Pharmaceuticals GAAP EPS of -$0.06 beats by $0.06
|
May 15 |
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates
|
Apr 15 |
We Think Anebulo Pharmaceuticals (NASDAQ:ANEB) Needs To Drive Business Growth Carefully
|